Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
The International Journal of Biological Markers|November 24, 1999
Blood concentrations of tumor necrosis factor-alpha in malignant lymphomas and their decrease as a predictor of disease control in response to low-dose subcutaneous immunotherapy with interleukin-2P Lissoni, S Bolis, M Mandalà, et al.
Anticancer Research|April 1, 2009
Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's diseaseF Villani, A Busia, M Villani, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1985
Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVDS Viviani, A Santoro, G Ragni, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1989
Hodgkin's disease: the Milan Cancer Institute experience with MOPP and ABVDG Bonadonna, P Valagussa, A Santoro, et al.
American Journal of Clinical Oncology|October 1, 1985
Prospective randomized trial in advanced malignant melanoma with cis-platinum, vindesine, and etoposide vs. cis-platinum, vindesine, and lomustineE Bajetta, R Buzzoni, S Viviani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remissionS Viviani, A Santoro, E Negretti, et al.
Medical Oncology (Northwood, London, England)|March 14, 2000
Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in Hodgkin's disease, the milan cancer institute experienceS Viviani, P Notti, V Bonfante, et al.
American Journal of Clinical Oncology|February 22, 2000
Late pulmonary effects in favorable stage I and IIA Hodgkin's disease treated with radiotherapy aloneF Villani, S Viviani, V Bonfante, et al.
Annals of Hematology|May 27, 2018
Treatment of classical Hodgkin lymphoma in the era of brentuximab vedotin and immune checkpoint inhibitorsA M Carella, P Corradini, A Mussetti, et al.
Cancer Investigation|May 15, 2003
Effect of an intensive chemotherapy followed by mediastinal irradiation on pulmonary and cardiac function in advanced Hodgkin's diseaseF Villani, A Fede Catania, A Laffranchi, et al.
Pageof 7